User menu

The Metabolic-fate of C-14 Or S-35 Labeled Tiadenol in Rabbit After Iv and Oral-administration

Bibliographic reference Desager, Jean-Pierre ; Costermans, Joseph ; Sclavons, Michel ; Harvengt, C.. The Metabolic-fate of C-14 Or S-35 Labeled Tiadenol in Rabbit After Iv and Oral-administration. In: European Journal of Drug Metabolism and Pharmacokinetics, Vol. 11, no. 3, p. 225-232 (1986)
Permanent URL
  1. Rousselet F. et Clenet M. (1972): étude d’un nouvel hypolipémiant, le bis(hydroxy-ethyl-thio)l — 10 décane: le LL 1558 ; II : étude métabolique. Thérapie,27, 413–422.
  2. Sirtori M., Montanari G., Gianfranceschi G., Malacrida M.G., Battistin P., Morazzoni G., Tremoli E., Colli S., Maderna P. and Sirtori C. (1983): Clofibrate and tiadenol treatment in hyperlipoproteinemias. Atherosclerosis,49, 149–161.
  3. Baggio G., Briani G., Fellin R., Martini S., Baiocchi M.R. and Crepaldi G. (1979): Effect of tiadenol on the concentration and composition of serum lipoproteins in familial hypercholesterolemia. Artery,5, 486–494.
  4. Tse F.L.S. and Happy J.M. (1982): Comparative pharmacokinetics of14C-tiadenol in the rat and the dog. Internal files from Sandoz (Hannover, USA).
  5. Mounie J., Goudonnet H., Bereksi-Reguig K., Escousse A. et Truchot R. (1983): Effets inducteurs du bis(hydroxyethylthio)-l,10-décane (tiadenol) sur les enzymes microsomales hépatiques chez le rat. J. Pharmacol. Paris,14, 171–182.
  6. Facino R.M., Carini M., Nava M.L. and Tofanetti O. (1983): Effects of chronic tiadenol administration on liver microsomal cytochrome P-450 and associated monooxygenases in the rat. Il Farmaco (Ed. Prat),38, 429–438.
  7. Kawashima Yoichi, Nakagawa Sayuri, Tachibana Yuka, Kozuka Hiroshi, Effects of peroxisome proliferators on fatty acid-binding protein in rat liver, 10.1016/0005-2760(83)90077-2
  8. Facino R.M., Carini M., Traldi P. and Tofanetti O. (1983): Field desorption-mass spectrometry: a useful tool for identification of S-oxidized metabolites of tiadenol.In: Chromatography and mass spectrometry in biomedical Sciences. (Frigerio A. Ed.),2, 57–70. (Elsevier, Amsterdam, The Netherlands).
  9. Assous E., Pouget M., Nadaud J., Tartary G., Henry M. et Duteil J. (1972): Étude d’un nouvel hypolipemiant, le bis(hydroxy-éthyé-thio)l,10 decane: LL 1558. I. Étude toxicologique et pharmacologique, Thérapie,27, 395–411.